Chronic Obstructive Pulmonary Diseases
9
1
1
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
11.1%
1 terminated out of 9 trials
80.0%
-6.5% vs benchmark
22%
2 trials in Phase 3/4
50%
2 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (9)
Protein, Sarcopenic Obesity, and COPD
Effect of IMT in Patients After Acute Exacerbations of COPD
Mepolizumab in Chronic Obstructive Pulmonary Diseases (COPD) With Eosinophilic Bronchitis
The Role of Ambulatory Oxygen in Improving the Effectiveness of Pulmonary Rehabilitation for COPD Patients
Effect of Magnesium Sulphate Infusion on Lung Mechanics and Oxygenation in COPD Patients Undergoing Total Laryngeal
The Efficacy and Safety of Electronic Cigarettes: a 5-year Follow-up Study
Comparing Online Pulmonary Rehabilitation 'myPR' Versus Conventional Pulmonary Rehabilitation for Patients With COPD
Trial of E-Health Platform Supported Care vs Usual Care After Exacerbation of COPD
The Roles of Neutrophil Elastase in Lung Cancer